Research Papers:
Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2207 views | HTML 2785 views | ?
Abstract
Marco Fidaleo1,2,*, Francesca Svetoni1,2,*, Elisabetta Volpe2, Belén Miñana3,4, Daniela Caporossi1, Maria Paola Paronetto1,2
1Department of Movement, Human and Health Sciences, University of Rome “Foro Italico”, Rome, Italy
2Laboratories of Cellular and Molecular Neurobiology and of Neuroimmunology, CERC, Fondazione Santa Lucia, Rome, Italy
3Centre de Regulació Genòmica, Barcelona, Spain
4Universitat Pompeu Fabra, Barcelona, Spain
*These authors have contributed equally to this work
Correspondence to:
Maria Paola Paronetto, e-mail: [email protected]
Keywords: Ewing sarcoma, alternative splicing, DNA damage, DHX9
Received: April 13, 2015 Accepted: September 21, 2015 Published: October 02, 2015
ABSTRACT
Alternative splicing plays a key role in the DNA damage response and in cancer. Ewing Sarcomas (ES) are aggressive tumors caused by different chromosomal translocations that yield in-frame fusion proteins driving transformation. RNA profiling reveals genes differentially regulated by UV light irradiation in two ES cell lines exhibiting different sensitivity to genotoxic stress. In particular, irradiation induces a new isoform of the RNA helicase DHX9 in the more sensitive SK-N-MC cells, which is targeted to nonsense-mediated decay (NMD), causing its downregulation. DHX9 protein forms a complex with RNA polymerase II (RNAPII) and EWS-FLI1 to enhance transcription. Silencing of DHX9 in ES cells sensitizes them to UV treatment and impairs recruitment of EWS-FLI1 to target genes, whereas DHX9 overexpression protects ES cells from genotoxic stress. Mechanistically, we found that UV light irradiation leads to enhanced phosphorylation and decreased processivity of RNAPII in SK-N-MC cells, which in turn causes inclusion of DHX9 exon 6A. A similar effect on DHX9 splicing was also elicited by treatment with the chemotherapeutic drug etoposide, indicating a more general mechanism of regulation in response to DNA damage. Our data identify a new NMD-linked splicing event in DHX9 with impact on EWS-FLI1 oncogenic activity and ES cell viability.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5033